In the PIONEER 5 trial, oral semaglutide demonstrated effectiveness in T2DM patients with moderate renal impairment, thereby offering a new treatment option [64]
If your sleep hygiene is wrecked, your diet is chaotic, and you're sedentary, these peptides will underperform spectacularly
In November 2024, the Biden administration proposed that Medicare and Medicaid be required to cover GLP-1 drugs for people with obesity
The tactics of modern-day regulatory trials
doi: 10.1056/NEJMe2401743
Novo Nordisk hit back almost immediately, placing an ad in The New York Times and USA Today called "Check Before You Inject." A company spokesperson said, at the point, that the ad was a "direct response" to the Hims & Hers' Super Bowl commercial